PRKAA1 and Parkinson disease: Accordingly, AMPK activation has been demonstrated to alleviate two major pathological hallmarks of PD, the degeneration of nigrostriatal dopaminergic neurons and the accumulation of α-synuclein in Lewy bodies in different PD model systems, including cell culture, fly, and rodent models (Table 2).